Fundraising Fox

Electra Therapeutics

Delaware corporation · 3 known investors

electra-therapeutics.com ↗

Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.

BiotechHealthtechMedical Devices

Founders & leadership

BS
Beth Seidenberg, M.D.Director
TG
Thomas Geninatti, Ph.D.Director
MF
Matthew FustDirector
CG
Carl Gordon, Ph.D.Director
NS
Nancy Stagliano, Ph.D.Director
Q(
Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director

Investors · 3

OrbiMedNew York · $1M – $75M
RA CapitalBoston
Westlake Village BioPartnersLos Angeles · $100K – $5M

Reported raises · per SEC filings

Form D private placements
▶$134.2MraisedOct 2025 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth Seidenberg, M.D.Director
  • Thomas Geninatti, Ph.D.Director
  • Matthew FustDirector
  • Carl Gordon, Ph.D.Director
  • Nancy Stagliano, Ph.D.Director
  • Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
Offering amount
$184.1M
Amount sold
$134.2M
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news